MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas

Journal of Human Genetics

Volumn 47, Issue 9, 2002, Pages 460-464

  Janssen, J W G ^a   Imoto, I ^b   Inoue, J ^b,c   Shimada, Y ^d   Ueda, M ^e   Imamura, M ^d   Bartram, C R ^a   Inazawa, J ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Carcinoma; CCND1; EMS1; Epigenetic; MYEOV

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; CELL SUBPOPULATION; CHROMOSOME 11Q; CONTROLLED STUDY; DEMETHYLATION; ESOPHAGUS CARCINOMA; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE INACTIVATION; GENE MAPPING; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE CCND1; ONCOGENE MYEOV; SQUAMOUS CELL CARCINOMA;

AZACITIDINE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN D1; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENE SILENCING; HUMANS; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0036376921     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380200065     Document Type: Article

References (28)

1. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1
2. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
3. Repression of genes by DNA methylation depends on CpG density and promoter strength: Evidence for involvement of a methyl-CpG binding protein
4. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma
5. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer
6. Sno is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus
7. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas
8. Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms
9. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)
10. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
11. Association of 59 CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells
12. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis
13. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
14. Novel targets for the 18p11.3 amplification frequently observed in esophageal squamous cell carcinomas
15. Cyclin DI overexpression in malignant lymphomas
16. Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: Possible involvement of the A TF3 and CENPF genes in the 1q32 amplicon
17. Silence of chromosomal amplifications in colon cancer
18. Cancer genetics
19. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck
20. Molecular analysis of 11q13 breakpoints in multiple myeloma
21. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review
22. Identification and cloning of two overexpressed genes, U21B311 PRADI and EMS1, within the amplified chromosome 11q13 region in human carcinomas
23. Amplification of oncogenes in human cancer cells
24. Characterization of 21 newly established esophageal cancer cell lines
25. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information
26. Histone acetylation and transcriptional regulatory mechanisms
27. Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma
28. Amplified genes in cancer in upper digestive tract